Embecta EMBC
NASDAQ EMBC
$6.86 +0.18 (+2.69%)
At close: Oct 22, 2026 · 4:00 PM EDT

Embecta (EMBC) Return on Sales [ROS] (2020 - 2026)

Updated

Embecta's Return on Sales [ROS] was 17.92% in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 13.89 percentage points from 31.81% a year earlier but up 2.14 percentage points from the prior quarter.

Analysis

Embecta (EMBC) Return on Sales [ROS] (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, Embecta's Return on Sales [ROS] was 21.94% through Jun 30, 2026, up 2.73 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it came in at 22.41%, up 7.56 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of -22.41 percentage points (FY2020 to FY2025).
  • In earlier fiscal years, Return on Sales [ROS] was 14.85% in FY2024 (-4.91 pp), 19.76% in FY2023 (-7.65 pp), 27.41% in FY2022 (-14.81 pp) and 42.22% in FY2021 (-2.60 pp).
  • Quarterly Return on Sales [ROS] has moved between -1.09% (fiscal Q4 2022) and 40.30% (fiscal Q1 2022) over five years.
  • Compared with a year earlier, Return on Sales [ROS] was higher in five of the last eight quarters, with an average year-over-year change of +3.41 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was fiscal Q1 2026 (a gain of 20.93 percentage points); the worst was fiscal Q4 2022 (a drop of 40.06 percentage points).
  • Per Business Quant data, EMBC's Return on Sales [ROS] in the three fiscal quarters before Q3 2026 was 15.78% (Q2 2026), 31.89% (Q1 2026) and 21.40% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 250.06 Bn 229.21 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 177.62 Bn 148.71 Bn 7.27 Bn 13.44%
3 Danaher 161.58 Bn 145.40 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 153.84 Bn 134.26 Bn 2.08 Bn 19.44%
5 Medtronic 123.63 Bn 89.50 Bn 6.34 Bn 18.08%
6 Stryker 117.79 Bn 103.90 Bn 4.50 Bn 25.18%
7 Boston Scientific 66.71 Bn 61.72 Bn 3.85 Bn 21.65%
8 Becton Dickinson 54.60 Bn 51.75 Bn 2.32 Bn 13.31%
9 Edwards Lifesciences 51.95 Bn 36.07 Bn 1.35 Bn 29.48%
10 Embecta 388.68 Mn -437.72 Mn 153.30 Mn 17.92%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.92%
Mar 31, 2026 15.78%
Dec 31, 2025 31.89%
Sep 30, 2025 21.40%
Jun 30, 2025 31.81%
Mar 31, 2025 24.29%
Dec 31, 2024 10.96%
Sep 30, 2024 9.16%
Jun 30, 2024 20.51%
Mar 31, 2024 13.65%
Dec 31, 2023 16.41%
Sep 30, 2023 9.15%
Jun 30, 2023 17.93%
Mar 31, 2023 20.06%
Dec 31, 2022 32.21%
Sep 30, 2022 -1.09%
Jun 30, 2022 33.36%
Mar 31, 2022 36.03%
Dec 31, 2021 40.30%
Sep 30, 2021 38.96%
API Access

Embecta Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=EMBC&period=max&api_key=YOUR_API_KEY